Sequana Medical N.V
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Sequana Medical N.V
Sequana Medical NV is a commercial-stage medical device company focused on the development of treatment solutions for the management of fluid overload in liver disease, malignant ascites, and heart failure. The company's products include an alfa pump, which provides a treatment solution for the long-term management of liver refractory ascites and malignant ascites with safety, efficacy, and quality of life benefits demonstrated in multiple clinical studies. The company's geographical segments include Switzerland, Germany, the United Kingdom, France, and the Rest of the world, out of which Germany accounts for the majority of the revenue.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Sequana Medical N.V stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Sequana Medical N.V by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Sequana Medical N.V is SEQUA:xbru. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Sequana Medical N.V has its primary listing on Euronext Brussels. You can trade Sequana Medical N.V with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Sequana Medical N.V is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Sequana Medical N.V as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Sequana Medical N.V.